Dr. William Loy Yap is a Baltimore, Maryland based male rheumatologist who is specialized in Rheumatology. Active license number of Dr. William Loy Yap for Rheumatology is D31256 in Maryland. Dr. William Loy Yap treat joint disease similar to orthopedists but do not perform surgeries. He diagnose and treat diseases of joints, muscle, bones and tendons which includes arthritis, back pain, muscle strains, common athletic injuries and 'collagen' diseases.
Complete Profile:
Dr. William Loy Yap speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Rheumatology
Credentials:
M.D.
Gender:
Male
Practice Address:
724 Maiden Choice Ln, Suite # 204, Baltimore, Maryland, 21228-5911
Phone:
410-744-6566
Fax:
410-744-7225
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1568438802
NPI Enumeration Date:
27 Feb, 2006
NPI Last Update On:
09 Jul, 2007
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. William Loy Yap are as mentioned below.
License Number
Specialization
State
Status
D31256
Rheumatologist
Maryland
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
724 Maiden Choice Ln, Suite # 204 Baltimore, Maryland
Zip:
21228-5911
Phone Number:
410-744-6566
Fax Number:
410-744-7225
Patients can reach Dr. William Loy Yap at 724 Maiden Choice Ln, Suite # 204, Baltimore, Maryland or can call to book an appointment on 410-744-6566. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.